Get Live Data

Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.50
Bid: 222.00
Ask: 223.00
Change: -0.50 (-0.22%)
Spread: 1.00 (0.45%)
Open: 220.00
High: 224.00
Low: 220.00
Prev. Close: 223.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

29 Nov 2023 07:00

RNS Number : 9671U
PureTech Health PLC
29 November 2023
 

29 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

28 November 2023

Number of ordinary shares purchased:

39,084

Highest price paid per share:

160.20p

Lowest price paid per share:

156.20p

Volume weighted average price paid per share:

157.74p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,665,041 ordinary shares in treasury and has 272,803,118 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,803,118 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

28/11/2023

08:34:24

568

160.2

XLON

00380079201TRLO0.1.1

28/11/2023

08:34:24

1136

160.2

XLON

00380079202TRLO0.1.1

28/11/2023

08:42:57

165

160

AQXE

00380081002TRLO0.1.1

28/11/2023

08:42:57

112

159

TRQX

00380081003TRLO0.1.1

28/11/2023

08:42:58

285

158.8

CHIX

00380081010TRLO0.1.1

28/11/2023

08:42:58

515

158.8

BATE

00380081011TRLO0.1.1

28/11/2023

08:42:58

283

158.8

CHIX

00380081012TRLO0.1.1

28/11/2023

09:23:39

33

158

CHIX

00380089760TRLO0.1.1

28/11/2023

09:34:46

32

158

CHIX

00380092577TRLO0.1.1

28/11/2023

09:49:50

27

158

CHIX

00380095595TRLO0.1.1

28/11/2023

09:54:14

160

158

CHIX

00380096480TRLO0.1.1

28/11/2023

09:54:18

35

158

CHIX

00380096496TRLO0.1.1

28/11/2023

10:00:22

13

158

CHIX

00380097883TRLO0.1.1

28/11/2023

10:02:04

12

158

CHIX

00380098248TRLO0.1.1

28/11/2023

10:09:56

1

158

CHIX

00380100256TRLO0.1.1

28/11/2023

10:41:47

568

158

XLON

00380107196TRLO0.1.1

28/11/2023

10:41:47

23

158

XLON

00380107197TRLO0.1.1

28/11/2023

10:41:47

156

158

CHIX

00380107199TRLO0.1.1

28/11/2023

10:41:47

3

158

XLON

00380107198TRLO0.1.1

28/11/2023

10:41:47

294

158

BATE

00380107201TRLO0.1.1

28/11/2023

10:41:47

542

158

XLON

00380107200TRLO0.1.1

28/11/2023

10:41:47

165

157.8

AQXE

00380107203TRLO0.1.1

28/11/2023

10:41:47

515

158

BATE

00380107202TRLO0.1.1

28/11/2023

10:41:47

99

158

CHIX

00380107205TRLO0.1.1

28/11/2023

10:41:47

394

158

CHIX

00380107206TRLO0.1.1

28/11/2023

10:41:47

174

158

CHIX

00380107204TRLO0.1.1

28/11/2023

10:41:50

112

156.8

TRQX

00380107213TRLO0.1.1

28/11/2023

10:41:50

58

156.8

TRQX

00380107214TRLO0.1.1

28/11/2023

10:43:09

503

157.4

XLON

00380107426TRLO0.1.1

28/11/2023

10:43:09

508

157.6

XLON

00380107427TRLO0.1.1

28/11/2023

11:31:00

20

157.6

CHIX

00380116100TRLO0.1.1

28/11/2023

12:02:01

548

157.6

CHIX

00380120585TRLO0.1.1

28/11/2023

12:02:01

452

157.6

CHIX

00380120586TRLO0.1.1

28/11/2023

12:02:01

280

157

BATE

00380120588TRLO0.1.1

28/11/2023

12:02:01

1136

157.6

XLON

00380120587TRLO0.1.1

28/11/2023

12:02:01

235

157

BATE

00380120589TRLO0.1.1

28/11/2023

12:02:01

111

157

TRQX

00380120590TRLO0.1.1

28/11/2023

12:03:18

359

157.6

XLON

00380120878TRLO0.1.1

28/11/2023

12:35:51

33

156.4

AQXE

00380125471TRLO0.1.1

28/11/2023

13:01:20

226

157

CHIX

00380129713TRLO0.1.1

28/11/2023

13:01:20

342

157

CHIX

00380129714TRLO0.1.1

28/11/2023

14:06:40

684

158

CHIX

00380142899TRLO0.1.1

28/11/2023

14:29:13

359

158

XLON

00380148094TRLO0.1.1

28/11/2023

14:29:13

4071

158

XLON

00380148095TRLO0.1.1

28/11/2023

14:43:45

568

158

CHIX

00380157548TRLO0.1.1

28/11/2023

14:43:45

568

158

CHIX

00380157549TRLO0.1.1

28/11/2023

14:43:45

1704

158

XLON

00380157550TRLO0.1.1

28/11/2023

14:43:46

515

157.4

BATE

00380157555TRLO0.1.1

28/11/2023

14:43:46

112

157.4

TRQX

00380157556TRLO0.1.1

28/11/2023

14:43:47

350

158

AQXE

00380157569TRLO0.1.1

28/11/2023

14:44:49

277

158

AQXE

00380158058TRLO0.1.1

28/11/2023

14:44:56

899

158

XLON

00380158102TRLO0.1.1

28/11/2023

14:44:56

200

158

XLON

00380158103TRLO0.1.1

28/11/2023

14:51:34

31

158

XLON

00380161062TRLO0.1.1

28/11/2023

14:53:32

200

158

XLON

00380161667TRLO0.1.1

28/11/2023

14:56:16

200

158

XLON

00380162541TRLO0.1.1

28/11/2023

15:01:56

165

158

AQXE

00380165129TRLO0.1.1

28/11/2023

15:04:05

397

158

CHIX

00380165992TRLO0.1.1

28/11/2023

15:05:35

1130

157.8

XLON

00380166467TRLO0.1.1

28/11/2023

15:05:35

211

157.8

XLON

00380166468TRLO0.1.1

28/11/2023

15:05:35

1318

158

XLON

00380166469TRLO0.1.1

28/11/2023

15:05:40

753

157.8

XLON

00380166498TRLO0.1.1

28/11/2023

15:05:40

206

157.8

XLON

00380166497TRLO0.1.1

28/11/2023

15:05:47

223

157.8

XLON

00380166547TRLO0.1.1

28/11/2023

15:05:55

358

157.8

XLON

00380166579TRLO0.1.1

28/11/2023

16:06:59

1131

157.2

XLON

00380193123TRLO0.1.1

28/11/2023

16:07:11

218

158.2

XLON

00380193201TRLO0.1.1

28/11/2023

16:07:54

5

157.2

XLON

00380193523TRLO0.1.1

28/11/2023

16:07:54

1699

157.2

XLON

00380193524TRLO0.1.1

28/11/2023

16:07:56

568

157

CHIX

00380193561TRLO0.1.1

28/11/2023

16:08:02

498

157.4

BATE

00380193601TRLO0.1.1

28/11/2023

16:21:47

502

157.4

XLON

00380201666TRLO0.1.1

28/11/2023

16:21:47

190

156.8

CHIX

00380201667TRLO0.1.1

28/11/2023

16:21:47

289

156.8

CHIX

00380201669TRLO0.1.1

28/11/2023

16:21:47

288

156.8

XLON

00380201670TRLO0.1.1

28/11/2023

16:21:47

848

156.8

XLON

00380201668TRLO0.1.1

28/11/2023

16:21:47

89

156.8

CHIX

00380201671TRLO0.1.1

28/11/2023

16:21:48

1000

157.2

BATE

00380201684TRLO0.1.1

28/11/2023

16:22:28

165

156.4

AQXE

00380202108TRLO0.1.1

28/11/2023

16:22:30

202

156.8

CHIX

00380202125TRLO0.1.1

28/11/2023

16:22:30

196

156.2

BATE

00380202126TRLO0.1.1

28/11/2023

16:22:33

1050

156.8

XLON

00380202182TRLO0.1.1

28/11/2023

16:22:33

317

156.8

XLON

00380202183TRLO0.1.1

28/11/2023

16:24:11

503

157.2

TRQX

00380203081TRLO0.1.1

28/11/2023

16:24:17

198

157

XLON

00380203129TRLO0.1.1

28/11/2023

16:24:23

197

157

XLON

00380203185TRLO0.1.1

28/11/2023

16:26:55

260

157.2

XLON

00380204605TRLO0.1.1

28/11/2023

16:26:55

537

157.2

CHIX

00380204609TRLO0.1.1

28/11/2023

16:29:41

473

157.2

XLON

00380206212TRLO0.1.1

28/11/2023

16:29:41

928

157.2

XLON

00380206213TRLO0.1.1

28/11/2023

16:29:42

1

157.2

XLON

00380206231TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSDLSLTFIV
12345678910
Date   Source Headline
9th May 202412:05 pmRNSPRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data
7th May 202412:05 pmRNSPRTC's Seaport Announces Board/Team Appointments
1st May 20247:00 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSFinal Results
18th Apr 20247:00 amRNSNotice of Results
16th Apr 202412:00 pmRNSPRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
11th Apr 202412:00 pmRNSFDA Grants PRTC's LYT-200 Fast Track Designation
9th Apr 20247:00 amRNSPRTC Launches Seaport w/ $100M; Leadership Changes
19th Mar 20247:00 amRNS$100M Tender Offer
18th Mar 20241:32 pmRNS$14B Acquisition of PRTC’s Karuna by BMS Completed
13th Mar 202411:00 amRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
6th Mar 20247:00 amRNSPDMR Notification RSU Vesting
27th Feb 202412:00 pmRNSPRTC to Present at Cowen and Leerink Conferences
27th Feb 20247:00 amRNSPRTC: Akili Positive Ph3 & Japan PMDA Submission
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20245:30 pmRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 202412:00 pmRNSPureTech to present at the JP Morgan Conference
3rd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20231:31 pmRNSBMY Acquires PRTC Founded Entity Karuna for $14B
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSPRTC Year End Update & Outlook for 2024
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.